A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women

Human Reproduction

Volumn 13, Issue 10, 1998, Pages 2688-2692

  Hedon, B ^a   Hugues, J N ^b   Emperaire, J C ^c   Chabaud, J J ^d   Barbereau, D ^e   Boujenah, A ^f   Howles, C M ^g   Truong, F ^h  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c Private Institute   (France)

^d CLINIQUE PASTEUR   (France)

^e Rhonalpin Institute   (France)

^f Muette Clinic   (France)

^g Serono International SA   (Switzerland)

^h Laboratoires Serono   (France)

Author keywords

Anovulation; Induction of ovulation; Low dose; r HFSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; RECOMBINANT FOLLITROPIN;

ADULT; ANIMAL CELL; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE INFERTILITY; HUMAN; MULTICENTER STUDY; NONHUMAN; OVARY DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031759990     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.10.2688     Document Type: Article

References (23)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1996) Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 757-760.
2. Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 293, 355-359.
3. Balen, A.H. (1993) Hypersecretion of LH: a significant cause of infertility and miscarriage. Br. J. Obstet. Gynaecol., 100, 1082-1089.
4. Bergh, C., Howles, C.M., Borg, K. et al. (1997) Recombinant human follicle stimulating hormone (Gonal F®) versus highly purified urinary FSH (Metrodin HP®); results of a randomised comparative study in women undergoing assisted reproductive techniques. Hum. Reprod., 12, 2133-2139.
5. Breckwoldt, M., Peters, F. and Geistövel, F. (1986) Classification and diagnosis of ovarian insufficiency. In Insler, V. and Lunenfeld, B. (eds), Infertility: Male and Female. Churchill Livingstone, Edinburgh, pp. 191-212.
6. Buvat, J., Buvat-Herbaut, M., Marcolin, G. et al. (1989) Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil. Steril., 52, 553-559.
7. Fauser, B.C. (1997) Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle stimulating hormone: the role of oestradiol. Hum. Reprod. Update, 3, 101-108.
8. Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol., 31, 87-120.
9. Gilling Smith, C. and Franks, S. (1993) Polycystic ovary syndrome. Reprod. Med. Rev., 2, 15-32.
10. Homburg, R., Armar, N.A., Eshel., A., et al. (1988) Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br. Med. J. 297, 1024-1026.
11. Homburg, R., Levy, T. and Ben-Rafael, Z. (1995) A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic-ovary syndrome. Fertil. Steril., 63, 729-733.
12. Howles, C.M., Macnamee, M.C., Edwards, R.G. et al. (1986) Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet, i, 521-522.
13. Hughes, E., Collins, J. and Vandekerckhove, P. (1996) Ovulation induction with urinary follicle stimulating hormone vs human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. In Cochrane Database of Systematic Reviews. The Cochrane Library.
14. Hull, M.G.R. (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynaecol. Endocrinol., 1, 235-245.
15. Hull, M.G.R. (1991) Gonadotrophin therapy in anovulatory fertility. In Howles, C.M. (ed.), Gonadotrophins, Gonadotrophin-Releasing Hormone Analogues and Growth Factors in Infertility: Future Perspectives. Medifax International, Alden Press, Oxford, pp. 56-70.
16. Loumaye, E., Martineau, I., Piazzi, A. et al. (1996) Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum. Reprod., 11 (Suppl. 1), 95-107.
17. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. and Coelingh Bennink, H.J.T. (1995) A prospective randomized, assessor-blind, multi-centre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in vitro fertilization. Hum. Reprod., 10, 2534-2540.
18. Sagle, M.A., Hamilton-Fairley, D., Kiddy, D.S. et al. (1991) A comparative, randomized study of low-dose human menopausal gonadotrophin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril., 55, 56-60.
19. Seibel, M.M., Kamrava, M.M., McArdle, C. et al. (1984) Treatment of polycystic ovarian disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int. J. Fertil., 29, 39-43.
20. Shoham, Z., Patel, A. and Jacobs, H.S. (1991) Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. Fertil. Steril., 55, 1051-1056.
21. Van Capellen, W.A., Kramer, P., van Leeuwen, E.C.M. et al. (1997) Induction of superovulation in cyclic rats by administration of decreasing doses of recombinant follicle stimulating hormone (Org 32489). Hum. Reprod., 12, 224-230.
22. White, D.M., Polson, D.W., Kiddy, D. et al. (1996) Extensive personal experience. Induction of ovulation with low-dose gonadotrophins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J. Clin. Endocrinol. Metab., 81, 3821-3824.
23. Yong, E.L., Ng, S.C., Chan, C.L.K. et al. (1997) Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotrophin for induction of ovulation. Gynaecol. Endocrinol, 11, 35-42.